nodes	percent_of_prediction	percent_of_DWPC	metapath
Cilazapril—SLC15A2—melanoma	0.672	0.829	CbGaD
Cilazapril—ABCB1—melanoma	0.138	0.17	CbGaD
Cilazapril—ACE—umbilical vein—melanoma	0.00534	0.154	CbGeAlD
Cilazapril—ACE—hindlimb—melanoma	0.00489	0.141	CbGeAlD
Cilazapril—ACE—arm—melanoma	0.00467	0.135	CbGeAlD
Cilazapril—ACE—appendage—melanoma	0.00419	0.121	CbGeAlD
Cilazapril—SLC15A1—Proton/oligonucleotide cotransporters—SLC15A2—melanoma	0.00416	0.284	CbGpPWpGaD
Cilazapril—ACE—endothelium—melanoma	0.00253	0.0732	CbGeAlD
Cilazapril—ACE—blood vessel—melanoma	0.00233	0.0675	CbGeAlD
Cilazapril—ACE—neck—melanoma	0.00167	0.0483	CbGeAlD
Cilazapril—SLC15A1—mammalian vulva—melanoma	0.00137	0.0398	CbGeAlD
Cilazapril—ACE—eye—melanoma	0.00124	0.0359	CbGeAlD
Cilazapril—SLC15A2—retina—melanoma	0.00107	0.031	CbGeAlD
Cilazapril—Fosinopril—SLC15A2—melanoma	0.00104	0.132	CrCbGaD
Cilazapril—ACE—mammalian vulva—melanoma	0.000985	0.0285	CbGeAlD
Cilazapril—Perindopril—SLC15A2—melanoma	0.000849	0.107	CrCbGaD
Cilazapril—Spirapril—SLC15A2—melanoma	0.000839	0.106	CrCbGaD
Cilazapril—ABCB1—blood vessel—melanoma	0.000821	0.0238	CbGeAlD
Cilazapril—Moexipril—SLC15A2—melanoma	0.000804	0.102	CrCbGaD
Cilazapril—Quinapril—SLC15A2—melanoma	0.000748	0.0945	CrCbGaD
Cilazapril—Trandolapril—SLC15A2—melanoma	0.000724	0.0915	CrCbGaD
Cilazapril—Ramipril—SLC15A2—melanoma	0.000724	0.0915	CrCbGaD
Cilazapril—ACE—head—melanoma	0.000705	0.0204	CbGeAlD
Cilazapril—Benazepril—SLC15A2—melanoma	0.000651	0.0822	CrCbGaD
Cilazapril—SLC15A2—head—melanoma	0.000615	0.0178	CbGeAlD
Cilazapril—SLC15A2—Amino acid and oligopeptide SLC transporters—SLC17A5—melanoma	0.000581	0.0396	CbGpPWpGaD
Cilazapril—SLC15A1—Amino acid and oligopeptide SLC transporters—SLC15A2—melanoma	0.00056	0.0382	CbGpPWpGaD
Cilazapril—SLC15A1—Amino acid and oligopeptide SLC transporters—SLC17A5—melanoma	0.000539	0.0368	CbGpPWpGaD
Cilazapril—ACE—lymph node—melanoma	0.000494	0.0143	CbGeAlD
Cilazapril—ABCB1—ABC-family proteins mediated transport—ABCB5—melanoma	0.000462	0.0315	CbGpPWpGaD
Cilazapril—ABCB1—retina—melanoma	0.000433	0.0125	CbGeAlD
Cilazapril—SLC15A2—lymph node—melanoma	0.00043	0.0125	CbGeAlD
Cilazapril—Mitiglinide—PPARG—melanoma	0.000421	0.0532	CrCbGaD
Cilazapril—Chills—Bleomycin—melanoma	0.000414	0.00312	CcSEcCtD
Cilazapril—Cardiac failure congestive—Docetaxel—melanoma	0.000413	0.00311	CcSEcCtD
Cilazapril—Hepatobiliary disease—Temozolomide—melanoma	0.00041	0.00309	CcSEcCtD
Cilazapril—Alopecia—Bleomycin—melanoma	0.000408	0.00307	CcSEcCtD
Cilazapril—Erythema multiforme—Dactinomycin—melanoma	0.000407	0.00306	CcSEcCtD
Cilazapril—Sinusitis—Temozolomide—melanoma	0.000407	0.00306	CcSEcCtD
Cilazapril—Hypoaesthesia—Carmustine—melanoma	0.000401	0.00302	CcSEcCtD
Cilazapril—Hot flush—Docetaxel—melanoma	0.0004	0.00301	CcSEcCtD
Cilazapril—Flushing—Dactinomycin—melanoma	0.0004	0.00301	CcSEcCtD
Cilazapril—Hypersensitivity—Vemurafenib—melanoma	0.000399	0.003	CcSEcCtD
Cilazapril—Menopausal symptoms—Docetaxel—melanoma	0.000397	0.00299	CcSEcCtD
Cilazapril—Atrial fibrillation—Docetaxel—melanoma	0.000395	0.00297	CcSEcCtD
Cilazapril—Renal impairment—Docetaxel—melanoma	0.000394	0.00296	CcSEcCtD
Cilazapril—Asthenia—Vemurafenib—melanoma	0.000389	0.00292	CcSEcCtD
Cilazapril—Visual impairment—Carmustine—melanoma	0.000389	0.00292	CcSEcCtD
Cilazapril—Hypoaesthesia—Temozolomide—melanoma	0.000388	0.00292	CcSEcCtD
Cilazapril—Pharyngitis—Temozolomide—melanoma	0.000387	0.00291	CcSEcCtD
Cilazapril—Chills—Dactinomycin—melanoma	0.000387	0.00291	CcSEcCtD
Cilazapril—Urinary tract disorder—Temozolomide—melanoma	0.000385	0.00289	CcSEcCtD
Cilazapril—Cardiac failure—Docetaxel—melanoma	0.000384	0.00289	CcSEcCtD
Cilazapril—Pruritus—Vemurafenib—melanoma	0.000383	0.00288	CcSEcCtD
Cilazapril—Urethral disorder—Temozolomide—melanoma	0.000382	0.00287	CcSEcCtD
Cilazapril—Alopecia—Dactinomycin—melanoma	0.000381	0.00286	CcSEcCtD
Cilazapril—Visual impairment—Temozolomide—melanoma	0.000375	0.00282	CcSEcCtD
Cilazapril—Nateglinide—SLC15A2—melanoma	0.000375	0.0474	CrCbGaD
Cilazapril—Gastrointestinal haemorrhage—Docetaxel—melanoma	0.000375	0.00282	CcSEcCtD
Cilazapril—Flushing—Carmustine—melanoma	0.000374	0.00281	CcSEcCtD
Cilazapril—Ill-defined disorder—Bleomycin—melanoma	0.000373	0.00281	CcSEcCtD
Cilazapril—Anaemia—Bleomycin—melanoma	0.000372	0.0028	CcSEcCtD
Cilazapril—Diarrhoea—Vemurafenib—melanoma	0.000371	0.00279	CcSEcCtD
Cilazapril—Migraine—Docetaxel—melanoma	0.000369	0.00277	CcSEcCtD
Cilazapril—Erythema multiforme—Temozolomide—melanoma	0.000368	0.00277	CcSEcCtD
Cilazapril—Tinnitus—Temozolomide—melanoma	0.000363	0.00273	CcSEcCtD
Cilazapril—Malaise—Bleomycin—melanoma	0.000363	0.00273	CcSEcCtD
Cilazapril—Cardiac disorder—Temozolomide—melanoma	0.000362	0.00272	CcSEcCtD
Cilazapril—Flushing—Temozolomide—melanoma	0.000362	0.00272	CcSEcCtD
Cilazapril—Arrhythmia—Carmustine—melanoma	0.00036	0.00271	CcSEcCtD
Cilazapril—Leukopenia—Bleomycin—melanoma	0.00036	0.00271	CcSEcCtD
Cilazapril—Dizziness—Vemurafenib—melanoma	0.000358	0.00269	CcSEcCtD
Cilazapril—Alopecia—Carmustine—melanoma	0.000356	0.00268	CcSEcCtD
Cilazapril—Angiopathy—Temozolomide—melanoma	0.000354	0.00266	CcSEcCtD
Cilazapril—Ataxia—Docetaxel—melanoma	0.000352	0.00265	CcSEcCtD
Cilazapril—Immune system disorder—Temozolomide—melanoma	0.000352	0.00265	CcSEcCtD
Cilazapril—Cough—Bleomycin—melanoma	0.000351	0.00264	CcSEcCtD
Cilazapril—Chills—Temozolomide—melanoma	0.00035	0.00263	CcSEcCtD
Cilazapril—Ill-defined disorder—Dactinomycin—melanoma	0.000348	0.00262	CcSEcCtD
Cilazapril—ABCB1—mammalian vulva—melanoma	0.000347	0.01	CbGeAlD
Cilazapril—Anaemia—Dactinomycin—melanoma	0.000347	0.00261	CcSEcCtD
Cilazapril—Liver function test abnormal—Docetaxel—melanoma	0.000346	0.0026	CcSEcCtD
Cilazapril—Vomiting—Vemurafenib—melanoma	0.000344	0.00259	CcSEcCtD
Cilazapril—Alopecia—Temozolomide—melanoma	0.000344	0.00259	CcSEcCtD
Cilazapril—Chest pain—Bleomycin—melanoma	0.000342	0.00258	CcSEcCtD
Cilazapril—Myalgia—Bleomycin—melanoma	0.000342	0.00258	CcSEcCtD
Cilazapril—SLC15A2—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC17A5—melanoma	0.000342	0.0233	CbGpPWpGaD
Cilazapril—Orthostatic hypotension—Docetaxel—melanoma	0.000342	0.00257	CcSEcCtD
Cilazapril—Rash—Vemurafenib—melanoma	0.000342	0.00257	CcSEcCtD
Cilazapril—Dermatitis—Vemurafenib—melanoma	0.000341	0.00257	CcSEcCtD
Cilazapril—Headache—Vemurafenib—melanoma	0.000339	0.00255	CcSEcCtD
Cilazapril—Discomfort—Bleomycin—melanoma	0.000338	0.00254	CcSEcCtD
Cilazapril—Malaise—Dactinomycin—melanoma	0.000338	0.00254	CcSEcCtD
Cilazapril—Toxic epidermal necrolysis—Docetaxel—melanoma	0.000337	0.00254	CcSEcCtD
Cilazapril—Leukopenia—Dactinomycin—melanoma	0.000336	0.00253	CcSEcCtD
Cilazapril—Dysgeusia—Temozolomide—melanoma	0.000332	0.0025	CcSEcCtD
Cilazapril—Confusional state—Bleomycin—melanoma	0.000331	0.00249	CcSEcCtD
Cilazapril—SLC15A1—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC15A2—melanoma	0.00033	0.0225	CbGpPWpGaD
Cilazapril—Tremor—Carmustine—melanoma	0.000329	0.00247	CcSEcCtD
Cilazapril—Oedema—Bleomycin—melanoma	0.000328	0.00247	CcSEcCtD
Cilazapril—Anaemia—Carmustine—melanoma	0.000324	0.00244	CcSEcCtD
Cilazapril—Nausea—Vemurafenib—melanoma	0.000322	0.00242	CcSEcCtD
Cilazapril—Thrombocytopenia—Bleomycin—melanoma	0.000321	0.00242	CcSEcCtD
Cilazapril—Myalgia—Dactinomycin—melanoma	0.000319	0.0024	CcSEcCtD
Cilazapril—Bronchospasm—Docetaxel—melanoma	0.000318	0.0024	CcSEcCtD
Cilazapril—Tremor—Temozolomide—melanoma	0.000318	0.00239	CcSEcCtD
Cilazapril—SLC15A1—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC17A5—melanoma	0.000318	0.0217	CbGpPWpGaD
Cilazapril—Discomfort—Dactinomycin—melanoma	0.000315	0.00237	CcSEcCtD
Cilazapril—Angina pectoris—Docetaxel—melanoma	0.000315	0.00237	CcSEcCtD
Cilazapril—Ill-defined disorder—Temozolomide—melanoma	0.000315	0.00237	CcSEcCtD
Cilazapril—Leukopenia—Carmustine—melanoma	0.000314	0.00236	CcSEcCtD
Cilazapril—Anaemia—Temozolomide—melanoma	0.000313	0.00236	CcSEcCtD
Cilazapril—Anorexia—Bleomycin—melanoma	0.000313	0.00235	CcSEcCtD
Cilazapril—Angioedema—Temozolomide—melanoma	0.00031	0.00233	CcSEcCtD
Cilazapril—Hypotension—Bleomycin—melanoma	0.000307	0.00231	CcSEcCtD
Cilazapril—Oedema—Dactinomycin—melanoma	0.000306	0.0023	CcSEcCtD
Cilazapril—Malaise—Temozolomide—melanoma	0.000306	0.0023	CcSEcCtD
Cilazapril—Vertigo—Temozolomide—melanoma	0.000305	0.00229	CcSEcCtD
Cilazapril—Leukopenia—Temozolomide—melanoma	0.000304	0.00228	CcSEcCtD
Cilazapril—Hypertension—Carmustine—melanoma	0.000303	0.00228	CcSEcCtD
Cilazapril—Neutropenia—Docetaxel—melanoma	0.000303	0.00228	CcSEcCtD
Cilazapril—Palpitations—Temozolomide—melanoma	0.0003	0.00225	CcSEcCtD
Cilazapril—Thrombocytopenia—Dactinomycin—melanoma	0.0003	0.00225	CcSEcCtD
Cilazapril—Musculoskeletal discomfort—Bleomycin—melanoma	0.000299	0.00225	CcSEcCtD
Cilazapril—Chest pain—Carmustine—melanoma	0.000299	0.00225	CcSEcCtD
Cilazapril—Myalgia—Carmustine—melanoma	0.000299	0.00225	CcSEcCtD
Cilazapril—Anxiety—Carmustine—melanoma	0.000298	0.00224	CcSEcCtD
Cilazapril—Cough—Temozolomide—melanoma	0.000296	0.00223	CcSEcCtD
Cilazapril—Paraesthesia—Bleomycin—melanoma	0.000295	0.00222	CcSEcCtD
Cilazapril—Hypertension—Temozolomide—melanoma	0.000293	0.0022	CcSEcCtD
Cilazapril—Dyspnoea—Bleomycin—melanoma	0.000293	0.0022	CcSEcCtD
Cilazapril—Anorexia—Dactinomycin—melanoma	0.000292	0.00219	CcSEcCtD
Cilazapril—Confusional state—Carmustine—melanoma	0.000289	0.00217	CcSEcCtD
Cilazapril—Myalgia—Temozolomide—melanoma	0.000289	0.00217	CcSEcCtD
Cilazapril—Arthralgia—Temozolomide—melanoma	0.000289	0.00217	CcSEcCtD
Cilazapril—Anxiety—Temozolomide—melanoma	0.000288	0.00216	CcSEcCtD
Cilazapril—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—melanoma	0.000287	0.00216	CcSEcCtD
Cilazapril—Oedema—Carmustine—melanoma	0.000286	0.00215	CcSEcCtD
Cilazapril—Stevens-Johnson syndrome—Docetaxel—melanoma	0.000286	0.00215	CcSEcCtD
Cilazapril—Discomfort—Temozolomide—melanoma	0.000285	0.00215	CcSEcCtD
Cilazapril—Decreased appetite—Bleomycin—melanoma	0.000285	0.00215	CcSEcCtD
Cilazapril—Acute coronary syndrome—Docetaxel—melanoma	0.000285	0.00214	CcSEcCtD
Cilazapril—Renal failure—Docetaxel—melanoma	0.000284	0.00213	CcSEcCtD
Cilazapril—Myocardial infarction—Docetaxel—melanoma	0.000283	0.00213	CcSEcCtD
Cilazapril—Dry mouth—Temozolomide—melanoma	0.000282	0.00212	CcSEcCtD
Cilazapril—Pain—Bleomycin—melanoma	0.000281	0.00211	CcSEcCtD
Cilazapril—Conjunctivitis—Docetaxel—melanoma	0.000281	0.00211	CcSEcCtD
Cilazapril—Thrombocytopenia—Carmustine—melanoma	0.00028	0.00211	CcSEcCtD
Cilazapril—Tachycardia—Carmustine—melanoma	0.00028	0.0021	CcSEcCtD
Cilazapril—Confusional state—Temozolomide—melanoma	0.000279	0.0021	CcSEcCtD
Cilazapril—Musculoskeletal discomfort—Dactinomycin—melanoma	0.000279	0.0021	CcSEcCtD
Cilazapril—Oedema—Temozolomide—melanoma	0.000277	0.00208	CcSEcCtD
Cilazapril—ACE—Peptide hormone metabolism—PAX6—melanoma	0.000275	0.0188	CbGpPWpGaD
Cilazapril—Anorexia—Carmustine—melanoma	0.000273	0.00205	CcSEcCtD
Cilazapril—Hepatobiliary disease—Docetaxel—melanoma	0.000273	0.00205	CcSEcCtD
Cilazapril—Epistaxis—Docetaxel—melanoma	0.000272	0.00205	CcSEcCtD
Cilazapril—Thrombocytopenia—Temozolomide—melanoma	0.000271	0.00204	CcSEcCtD
Cilazapril—Feeling abnormal—Bleomycin—melanoma	0.00027	0.00203	CcSEcCtD
Cilazapril—Agranulocytosis—Docetaxel—melanoma	0.000269	0.00203	CcSEcCtD
Cilazapril—Skin disorder—Temozolomide—melanoma	0.000269	0.00202	CcSEcCtD
Cilazapril—Hypotension—Carmustine—melanoma	0.000268	0.00201	CcSEcCtD
Cilazapril—Hyperhidrosis—Temozolomide—melanoma	0.000268	0.00201	CcSEcCtD
Cilazapril—Decreased appetite—Dactinomycin—melanoma	0.000266	0.002	CcSEcCtD
Cilazapril—Fatigue—Dactinomycin—melanoma	0.000264	0.00199	CcSEcCtD
Cilazapril—Anorexia—Temozolomide—melanoma	0.000264	0.00199	CcSEcCtD
Cilazapril—Pain—Dactinomycin—melanoma	0.000262	0.00197	CcSEcCtD
Cilazapril—Musculoskeletal discomfort—Carmustine—melanoma	0.000261	0.00196	CcSEcCtD
Cilazapril—Urticaria—Bleomycin—melanoma	0.000261	0.00196	CcSEcCtD
Cilazapril—Rhinitis—Docetaxel—melanoma	0.00026	0.00195	CcSEcCtD
Cilazapril—Insomnia—Carmustine—melanoma	0.000259	0.00195	CcSEcCtD
Cilazapril—Hypoaesthesia—Docetaxel—melanoma	0.000258	0.00194	CcSEcCtD
Cilazapril—Paraesthesia—Carmustine—melanoma	0.000257	0.00193	CcSEcCtD
Cilazapril—Pharyngitis—Docetaxel—melanoma	0.000257	0.00193	CcSEcCtD
Cilazapril—Urinary tract disorder—Docetaxel—melanoma	0.000256	0.00192	CcSEcCtD
Cilazapril—Dyspnoea—Carmustine—melanoma	0.000255	0.00192	CcSEcCtD
Cilazapril—Somnolence—Carmustine—melanoma	0.000255	0.00192	CcSEcCtD
Cilazapril—Urethral disorder—Docetaxel—melanoma	0.000254	0.00191	CcSEcCtD
Cilazapril—Feeling abnormal—Dactinomycin—melanoma	0.000252	0.0019	CcSEcCtD
Cilazapril—Musculoskeletal discomfort—Temozolomide—melanoma	0.000252	0.0019	CcSEcCtD
Cilazapril—Insomnia—Temozolomide—melanoma	0.00025	0.00188	CcSEcCtD
Cilazapril—Gastrointestinal pain—Dactinomycin—melanoma	0.00025	0.00188	CcSEcCtD
Cilazapril—Visual impairment—Docetaxel—melanoma	0.00025	0.00188	CcSEcCtD
Cilazapril—Decreased appetite—Carmustine—melanoma	0.000249	0.00187	CcSEcCtD
Cilazapril—Paraesthesia—Temozolomide—melanoma	0.000249	0.00187	CcSEcCtD
Cilazapril—ABCB1—head—melanoma	0.000248	0.00718	CbGeAlD
Cilazapril—Gastrointestinal disorder—Carmustine—melanoma	0.000247	0.00186	CcSEcCtD
Cilazapril—Dyspnoea—Temozolomide—melanoma	0.000247	0.00186	CcSEcCtD
Cilazapril—Somnolence—Temozolomide—melanoma	0.000246	0.00185	CcSEcCtD
Cilazapril—Erythema multiforme—Docetaxel—melanoma	0.000245	0.00184	CcSEcCtD
Cilazapril—Pain—Carmustine—melanoma	0.000245	0.00184	CcSEcCtD
Cilazapril—Constipation—Carmustine—melanoma	0.000245	0.00184	CcSEcCtD
Cilazapril—Dyspepsia—Temozolomide—melanoma	0.000244	0.00183	CcSEcCtD
Cilazapril—Abdominal pain—Dactinomycin—melanoma	0.000242	0.00182	CcSEcCtD
Cilazapril—Hypersensitivity—Bleomycin—melanoma	0.000242	0.00182	CcSEcCtD
Cilazapril—SLC15A2—Amino acid and oligopeptide SLC transporters—SLC5A5—melanoma	0.000241	0.0165	CbGpPWpGaD
Cilazapril—Decreased appetite—Temozolomide—melanoma	0.000241	0.00181	CcSEcCtD
Cilazapril—Cardiac disorder—Docetaxel—melanoma	0.00024	0.00181	CcSEcCtD
Cilazapril—Flushing—Docetaxel—melanoma	0.00024	0.00181	CcSEcCtD
Cilazapril—Gastrointestinal disorder—Temozolomide—melanoma	0.000239	0.0018	CcSEcCtD
Cilazapril—Fatigue—Temozolomide—melanoma	0.000239	0.0018	CcSEcCtD
Cilazapril—Pain—Temozolomide—melanoma	0.000237	0.00178	CcSEcCtD
Cilazapril—Constipation—Temozolomide—melanoma	0.000237	0.00178	CcSEcCtD
Cilazapril—Feeling abnormal—Carmustine—melanoma	0.000236	0.00178	CcSEcCtD
Cilazapril—Asthenia—Bleomycin—melanoma	0.000235	0.00177	CcSEcCtD
Cilazapril—Angiopathy—Docetaxel—melanoma	0.000235	0.00177	CcSEcCtD
Cilazapril—Gastrointestinal pain—Carmustine—melanoma	0.000234	0.00176	CcSEcCtD
Cilazapril—Immune system disorder—Docetaxel—melanoma	0.000234	0.00176	CcSEcCtD
Cilazapril—Chills—Docetaxel—melanoma	0.000232	0.00175	CcSEcCtD
Cilazapril—Pruritus—Bleomycin—melanoma	0.000232	0.00175	CcSEcCtD
Cilazapril—Arrhythmia—Docetaxel—melanoma	0.000231	0.00174	CcSEcCtD
Cilazapril—Alopecia—Docetaxel—melanoma	0.000229	0.00172	CcSEcCtD
Cilazapril—Feeling abnormal—Temozolomide—melanoma	0.000228	0.00172	CcSEcCtD
Cilazapril—Abdominal pain—Carmustine—melanoma	0.000226	0.0017	CcSEcCtD
Cilazapril—Gastrointestinal pain—Temozolomide—melanoma	0.000226	0.0017	CcSEcCtD
Cilazapril—Hypersensitivity—Dactinomycin—melanoma	0.000225	0.0017	CcSEcCtD
Cilazapril—SLC15A1—Amino acid and oligopeptide SLC transporters—SLC5A5—melanoma	0.000224	0.0153	CbGpPWpGaD
Cilazapril—Dysgeusia—Docetaxel—melanoma	0.000221	0.00166	CcSEcCtD
Cilazapril—Urticaria—Temozolomide—melanoma	0.00022	0.00165	CcSEcCtD
Cilazapril—Asthenia—Dactinomycin—melanoma	0.00022	0.00165	CcSEcCtD
Cilazapril—Abdominal pain—Temozolomide—melanoma	0.000219	0.00165	CcSEcCtD
Cilazapril—Muscle spasms—Docetaxel—melanoma	0.000217	0.00163	CcSEcCtD
Cilazapril—Nateglinide—PPARG—melanoma	0.000214	0.0271	CrCbGaD
Cilazapril—Hypersensitivity—Carmustine—melanoma	0.000211	0.00159	CcSEcCtD
Cilazapril—Diarrhoea—Dactinomycin—melanoma	0.000209	0.00158	CcSEcCtD
Cilazapril—Vomiting—Bleomycin—melanoma	0.000209	0.00157	CcSEcCtD
Cilazapril—Anaemia—Docetaxel—melanoma	0.000208	0.00157	CcSEcCtD
Cilazapril—Rash—Bleomycin—melanoma	0.000207	0.00156	CcSEcCtD
Cilazapril—Dermatitis—Bleomycin—melanoma	0.000207	0.00156	CcSEcCtD
Cilazapril—Asthenia—Carmustine—melanoma	0.000206	0.00155	CcSEcCtD
Cilazapril—Hypersensitivity—Temozolomide—melanoma	0.000204	0.00153	CcSEcCtD
Cilazapril—Syncope—Docetaxel—melanoma	0.000202	0.00152	CcSEcCtD
Cilazapril—Leukopenia—Docetaxel—melanoma	0.000202	0.00152	CcSEcCtD
Cilazapril—Palpitations—Docetaxel—melanoma	0.000199	0.0015	CcSEcCtD
Cilazapril—Asthenia—Temozolomide—melanoma	0.000199	0.00149	CcSEcCtD
Cilazapril—Loss of consciousness—Docetaxel—melanoma	0.000198	0.00149	CcSEcCtD
Cilazapril—Cough—Docetaxel—melanoma	0.000197	0.00148	CcSEcCtD
Cilazapril—Diarrhoea—Carmustine—melanoma	0.000196	0.00147	CcSEcCtD
Cilazapril—Pruritus—Temozolomide—melanoma	0.000196	0.00147	CcSEcCtD
Cilazapril—Nausea—Bleomycin—melanoma	0.000195	0.00147	CcSEcCtD
Cilazapril—Hypertension—Docetaxel—melanoma	0.000195	0.00146	CcSEcCtD
Cilazapril—Vomiting—Dactinomycin—melanoma	0.000195	0.00146	CcSEcCtD
Cilazapril—Rash—Dactinomycin—melanoma	0.000193	0.00145	CcSEcCtD
Cilazapril—Arthralgia—Docetaxel—melanoma	0.000192	0.00144	CcSEcCtD
Cilazapril—Chest pain—Docetaxel—melanoma	0.000192	0.00144	CcSEcCtD
Cilazapril—Myalgia—Docetaxel—melanoma	0.000192	0.00144	CcSEcCtD
Cilazapril—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—melanoma	0.000191	0.00143	CcSEcCtD
Cilazapril—Dizziness—Carmustine—melanoma	0.000189	0.00142	CcSEcCtD
Cilazapril—Diarrhoea—Temozolomide—melanoma	0.000189	0.00142	CcSEcCtD
Cilazapril—Dry mouth—Docetaxel—melanoma	0.000188	0.00141	CcSEcCtD
Cilazapril—Confusional state—Docetaxel—melanoma	0.000186	0.0014	CcSEcCtD
Cilazapril—Oedema—Docetaxel—melanoma	0.000184	0.00138	CcSEcCtD
Cilazapril—Dizziness—Temozolomide—melanoma	0.000183	0.00138	CcSEcCtD
Cilazapril—Vomiting—Carmustine—melanoma	0.000182	0.00137	CcSEcCtD
Cilazapril—Nausea—Dactinomycin—melanoma	0.000182	0.00137	CcSEcCtD
Cilazapril—Shock—Docetaxel—melanoma	0.000181	0.00136	CcSEcCtD
Cilazapril—Rash—Carmustine—melanoma	0.000181	0.00136	CcSEcCtD
Cilazapril—Dermatitis—Carmustine—melanoma	0.00018	0.00136	CcSEcCtD
Cilazapril—Thrombocytopenia—Docetaxel—melanoma	0.00018	0.00136	CcSEcCtD
Cilazapril—Tachycardia—Docetaxel—melanoma	0.00018	0.00135	CcSEcCtD
Cilazapril—Headache—Carmustine—melanoma	0.000179	0.00135	CcSEcCtD
Cilazapril—Skin disorder—Docetaxel—melanoma	0.000179	0.00135	CcSEcCtD
Cilazapril—Vomiting—Temozolomide—melanoma	0.000176	0.00132	CcSEcCtD
Cilazapril—Anorexia—Docetaxel—melanoma	0.000175	0.00132	CcSEcCtD
Cilazapril—Rash—Temozolomide—melanoma	0.000175	0.00131	CcSEcCtD
Cilazapril—Dermatitis—Temozolomide—melanoma	0.000174	0.00131	CcSEcCtD
Cilazapril—Perindopril—ABCB1—melanoma	0.000174	0.022	CrCbGaD
Cilazapril—ABCB1—lymph node—melanoma	0.000174	0.00503	CbGeAlD
Cilazapril—Headache—Temozolomide—melanoma	0.000173	0.0013	CcSEcCtD
Cilazapril—Hypotension—Docetaxel—melanoma	0.000172	0.00129	CcSEcCtD
Cilazapril—Nausea—Carmustine—melanoma	0.00017	0.00128	CcSEcCtD
Cilazapril—ACE—Metabolism of proteins—ADAMTS20—melanoma	0.00017	0.0116	CbGpPWpGaD
Cilazapril—ACE—Metabolism of proteins—PIGU—melanoma	0.00017	0.0116	CbGpPWpGaD
Cilazapril—Musculoskeletal discomfort—Docetaxel—melanoma	0.000168	0.00126	CcSEcCtD
Cilazapril—Insomnia—Docetaxel—melanoma	0.000166	0.00125	CcSEcCtD
Cilazapril—Paraesthesia—Docetaxel—melanoma	0.000165	0.00124	CcSEcCtD
Cilazapril—Nausea—Temozolomide—melanoma	0.000164	0.00124	CcSEcCtD
Cilazapril—Dyspnoea—Docetaxel—melanoma	0.000164	0.00123	CcSEcCtD
Cilazapril—Somnolence—Docetaxel—melanoma	0.000164	0.00123	CcSEcCtD
Cilazapril—Dyspepsia—Docetaxel—melanoma	0.000162	0.00122	CcSEcCtD
Cilazapril—Decreased appetite—Docetaxel—melanoma	0.00016	0.0012	CcSEcCtD
Cilazapril—Gastrointestinal disorder—Docetaxel—melanoma	0.000159	0.0012	CcSEcCtD
Cilazapril—Fatigue—Docetaxel—melanoma	0.000159	0.00119	CcSEcCtD
Cilazapril—Pain—Docetaxel—melanoma	0.000157	0.00118	CcSEcCtD
Cilazapril—Constipation—Docetaxel—melanoma	0.000157	0.00118	CcSEcCtD
Cilazapril—ACE—Metabolism of proteins—ARL2—melanoma	0.000155	0.0106	CbGpPWpGaD
Cilazapril—SLC15A2—Transmembrane transport of small molecules—ABCB5—melanoma	0.000154	0.0105	CbGpPWpGaD
Cilazapril—Lisinopril—ABCB1—melanoma	0.000154	0.0194	CrCbGaD
Cilazapril—SLC15A2—SLC-mediated transmembrane transport—SLC17A5—melanoma	0.000153	0.0104	CbGpPWpGaD
Cilazapril—Feeling abnormal—Docetaxel—melanoma	0.000152	0.00114	CcSEcCtD
Cilazapril—Gastrointestinal pain—Docetaxel—melanoma	0.000151	0.00113	CcSEcCtD
Cilazapril—SLC15A1—SLC-mediated transmembrane transport—SLC15A2—melanoma	0.000147	0.0101	CbGpPWpGaD
Cilazapril—Abdominal pain—Docetaxel—melanoma	0.000146	0.00109	CcSEcCtD
Cilazapril—ABCB1—HIF-1-alpha transcription factor network—ARNT—melanoma	0.000144	0.0098	CbGpPWpGaD
Cilazapril—SLC15A1—Transmembrane transport of small molecules—ABCB5—melanoma	0.000143	0.00973	CbGpPWpGaD
Cilazapril—SLC15A2—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC5A5—melanoma	0.000142	0.00969	CbGpPWpGaD
Cilazapril—SLC15A1—SLC-mediated transmembrane transport—SLC17A5—melanoma	0.000142	0.00968	CbGpPWpGaD
Cilazapril—SLC15A2—SLC-mediated transmembrane transport—SLC6A11—melanoma	0.000139	0.00947	CbGpPWpGaD
Cilazapril—Hypersensitivity—Docetaxel—melanoma	0.000136	0.00102	CcSEcCtD
Cilazapril—ABCB1—Drug Induction of Bile Acid Pathway—VDR—melanoma	0.000134	0.00917	CbGpPWpGaD
Cilazapril—Asthenia—Docetaxel—melanoma	0.000132	0.000994	CcSEcCtD
Cilazapril—SLC15A1—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC5A5—melanoma	0.000132	0.009	CbGpPWpGaD
Cilazapril—Pruritus—Docetaxel—melanoma	0.00013	0.00098	CcSEcCtD
Cilazapril—SLC15A1—SLC-mediated transmembrane transport—SLC6A11—melanoma	0.000129	0.00879	CbGpPWpGaD
Cilazapril—Diarrhoea—Docetaxel—melanoma	0.000126	0.000948	CcSEcCtD
Cilazapril—ACE—Peptide hormone metabolism—IGF1—melanoma	0.000125	0.00854	CbGpPWpGaD
Cilazapril—Dizziness—Docetaxel—melanoma	0.000122	0.000916	CcSEcCtD
Cilazapril—Vomiting—Docetaxel—melanoma	0.000117	0.000881	CcSEcCtD
Cilazapril—Rash—Docetaxel—melanoma	0.000116	0.000873	CcSEcCtD
Cilazapril—Dermatitis—Docetaxel—melanoma	0.000116	0.000872	CcSEcCtD
Cilazapril—Headache—Docetaxel—melanoma	0.000115	0.000868	CcSEcCtD
Cilazapril—ACE—Metabolism of proteins—SLC17A5—melanoma	0.000113	0.00772	CbGpPWpGaD
Cilazapril—Enalapril—ABCB1—melanoma	0.000113	0.0142	CrCbGaD
Cilazapril—Nausea—Docetaxel—melanoma	0.000109	0.000823	CcSEcCtD
Cilazapril—ACE—Metabolism of proteins—ADAMTS13—melanoma	0.000109	0.00745	CbGpPWpGaD
Cilazapril—SLC15A2—Transmembrane transport of small molecules—ARL2—melanoma	0.000107	0.00727	CbGpPWpGaD
Cilazapril—ABCB1—HIF-1-alpha transcription factor network—NDRG1—melanoma	0.000105	0.00717	CbGpPWpGaD
Cilazapril—ABCB1—HIF-1-alpha transcription factor network—MCL1—melanoma	0.000105	0.00717	CbGpPWpGaD
Cilazapril—SLC15A1—Transmembrane transport of small molecules—ARL2—melanoma	9.89e-05	0.00674	CbGpPWpGaD
Cilazapril—ACE—Peptide hormone metabolism—CTNNB1—melanoma	9.29e-05	0.00634	CbGpPWpGaD
Cilazapril—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—SKP2—melanoma	8.6e-05	0.00587	CbGpPWpGaD
Cilazapril—ACE—Metabolism of proteins—RPS3—melanoma	8.15e-05	0.00556	CbGpPWpGaD
Cilazapril—Nateglinide—ALB—melanoma	8.07e-05	0.0102	CrCbGaD
Cilazapril—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—EPO—melanoma	7.94e-05	0.00541	CbGpPWpGaD
Cilazapril—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—GAB2—melanoma	7.87e-05	0.00537	CbGpPWpGaD
Cilazapril—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—FLT1—melanoma	7.83e-05	0.00534	CbGpPWpGaD
Cilazapril—SLC15A2—Transmembrane transport of small molecules—SLC17A5—melanoma	7.77e-05	0.0053	CbGpPWpGaD
Cilazapril—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—melanoma	7.72e-05	0.00526	CbGpPWpGaD
Cilazapril—SLC15A1—Transmembrane transport of small molecules—SLC15A2—melanoma	7.49e-05	0.00511	CbGpPWpGaD
Cilazapril—SLC15A1—Transmembrane transport of small molecules—SLC17A5—melanoma	7.21e-05	0.00492	CbGpPWpGaD
Cilazapril—ABCB1—Allograft Rejection—FOXP3—melanoma	7.15e-05	0.00488	CbGpPWpGaD
Cilazapril—ABCB1—HIF-1-alpha transcription factor network—ETS1—melanoma	7.1e-05	0.00485	CbGpPWpGaD
Cilazapril—SLC15A2—Transmembrane transport of small molecules—SLC6A11—melanoma	7.06e-05	0.00481	CbGpPWpGaD
Cilazapril—SLC15A1—Transmembrane transport of small molecules—SLC6A11—melanoma	6.55e-05	0.00447	CbGpPWpGaD
Cilazapril—SLC15A2—SLC-mediated transmembrane transport—SLC5A5—melanoma	6.35e-05	0.00433	CbGpPWpGaD
Cilazapril—ABCB1—HIF-1-alpha transcription factor network—EPO—melanoma	6.25e-05	0.00427	CbGpPWpGaD
Cilazapril—SLC15A1—SLC-mediated transmembrane transport—SLC5A5—melanoma	5.89e-05	0.00402	CbGpPWpGaD
Cilazapril—ABCB1—HIF-1-alpha transcription factor network—CXCR4—melanoma	5.83e-05	0.00398	CbGpPWpGaD
Cilazapril—ABCB1—Integrated Pancreatic Cancer Pathway—CAPN1—melanoma	5.58e-05	0.0038	CbGpPWpGaD
Cilazapril—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—melanoma	5.38e-05	0.00367	CbGpPWpGaD
Cilazapril—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—PDGFRA—melanoma	5.37e-05	0.00366	CbGpPWpGaD
Cilazapril—ACE—Metabolism of proteins—PAX6—melanoma	5.2e-05	0.00354	CbGpPWpGaD
Cilazapril—ACE—Metabolism of proteins—HSPA5—melanoma	4.99e-05	0.00341	CbGpPWpGaD
Cilazapril—ABCB1—Allograft Rejection—CTLA4—melanoma	4.92e-05	0.00335	CbGpPWpGaD
Cilazapril—ABCB1—Transmembrane transport of small molecules—ABCB5—melanoma	4.82e-05	0.00329	CbGpPWpGaD
Cilazapril—ABCB1—Integrated Pancreatic Cancer Pathway—NODAL—melanoma	4.5e-05	0.00307	CbGpPWpGaD
Cilazapril—ABCB1—HIF-1-alpha transcription factor network—EDN1—melanoma	4.47e-05	0.00305	CbGpPWpGaD
Cilazapril—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—KIT—melanoma	4.16e-05	0.00284	CbGpPWpGaD
Cilazapril—ABCB1—Integrated Pancreatic Cancer Pathway—MAP3K5—melanoma	4.01e-05	0.00273	CbGpPWpGaD
Cilazapril—ABCB1—Integrated Pancreatic Cancer Pathway—CASP10—melanoma	4.01e-05	0.00273	CbGpPWpGaD
Cilazapril—ABCB1—Allograft Rejection—CD86—melanoma	3.9e-05	0.00266	CbGpPWpGaD
Cilazapril—ABCB1—HIF-1-alpha transcription factor network—TERT—melanoma	3.89e-05	0.00266	CbGpPWpGaD
Cilazapril—ABCB1—Allograft Rejection—IL10—melanoma	3.83e-05	0.00261	CbGpPWpGaD
Cilazapril—ABCB1—HIF-1-alpha transcription factor network—HIF1A—melanoma	3.72e-05	0.00254	CbGpPWpGaD
Cilazapril—ABCB1—Allograft Rejection—IL4—melanoma	3.72e-05	0.00254	CbGpPWpGaD
Cilazapril—ABCB1—Integrated Pancreatic Cancer Pathway—DCC—melanoma	3.7e-05	0.00252	CbGpPWpGaD
Cilazapril—ABCB1—Allograft Rejection—PDGFRA—melanoma	3.66e-05	0.0025	CbGpPWpGaD
Cilazapril—ABCB1—Allograft Rejection—HLA-B—melanoma	3.64e-05	0.00248	CbGpPWpGaD
Cilazapril—ABCB1—Integrated Pancreatic Cancer Pathway—APAF1—melanoma	3.59e-05	0.00245	CbGpPWpGaD
Cilazapril—ABCB1—Allograft Rejection—FASLG—melanoma	3.56e-05	0.00243	CbGpPWpGaD
Cilazapril—ABCB1—Allograft Rejection—FAS—melanoma	3.43e-05	0.00234	CbGpPWpGaD
Cilazapril—ABCB1—Integrated Pancreatic Cancer Pathway—WT1—melanoma	3.41e-05	0.00232	CbGpPWpGaD
Cilazapril—ABCB1—HIF-1-alpha transcription factor network—NOS2—melanoma	3.39e-05	0.00231	CbGpPWpGaD
Cilazapril—ABCB1—Allograft Rejection—HLA-A—melanoma	3.37e-05	0.0023	CbGpPWpGaD
Cilazapril—ABCB1—Transmembrane transport of small molecules—ARL2—melanoma	3.34e-05	0.00228	CbGpPWpGaD
Cilazapril—SLC15A2—Transmembrane transport of small molecules—SLC5A5—melanoma	3.23e-05	0.0022	CbGpPWpGaD
Cilazapril—ABCB1—Allograft Rejection—HLA-DRB1—melanoma	3.08e-05	0.0021	CbGpPWpGaD
Cilazapril—SLC15A2—SLC-mediated transmembrane transport—ALB—melanoma	3.03e-05	0.00207	CbGpPWpGaD
Cilazapril—SLC15A1—Transmembrane transport of small molecules—SLC5A5—melanoma	2.99e-05	0.00204	CbGpPWpGaD
Cilazapril—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—CDKN1B—melanoma	2.99e-05	0.00204	CbGpPWpGaD
Cilazapril—ACE—Metabolism of proteins—MMP1—melanoma	2.96e-05	0.00202	CbGpPWpGaD
Cilazapril—ABCB1—Allograft Rejection—CD80—melanoma	2.85e-05	0.00194	CbGpPWpGaD
Cilazapril—SLC15A1—SLC-mediated transmembrane transport—ALB—melanoma	2.81e-05	0.00192	CbGpPWpGaD
Cilazapril—ABCB1—Allograft Rejection—CASP8—melanoma	2.65e-05	0.0018	CbGpPWpGaD
Cilazapril—ABCB1—Transmembrane transport of small molecules—SLC15A2—melanoma	2.53e-05	0.00173	CbGpPWpGaD
Cilazapril—SLC15A2—Transmembrane transport of small molecules—ABCB1—melanoma	2.46e-05	0.00168	CbGpPWpGaD
Cilazapril—ABCB1—Transmembrane transport of small molecules—SLC17A5—melanoma	2.44e-05	0.00166	CbGpPWpGaD
Cilazapril—ACE—Metabolism of proteins—IGF1—melanoma	2.36e-05	0.00161	CbGpPWpGaD
Cilazapril—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—melanoma	2.29e-05	0.00156	CbGpPWpGaD
Cilazapril—ACE—Metabolism of proteins—MMP2—melanoma	2.29e-05	0.00156	CbGpPWpGaD
Cilazapril—SLC15A1—Transmembrane transport of small molecules—ABCB1—melanoma	2.28e-05	0.00156	CbGpPWpGaD
Cilazapril—ABCB1—Allograft Rejection—IFNG—melanoma	2.25e-05	0.00153	CbGpPWpGaD
Cilazapril—ABCB1—Transmembrane transport of small molecules—SLC6A11—melanoma	2.21e-05	0.00151	CbGpPWpGaD
Cilazapril—ABCB1—Allograft Rejection—CXCL8—melanoma	2.09e-05	0.00143	CbGpPWpGaD
Cilazapril—ABCB1—Allograft Rejection—CASP3—melanoma	2e-05	0.00137	CbGpPWpGaD
Cilazapril—ABCB1—Allograft Rejection—IL2—melanoma	2e-05	0.00136	CbGpPWpGaD
Cilazapril—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN2B—melanoma	1.99e-05	0.00136	CbGpPWpGaD
Cilazapril—ABCB1—HIF-1-alpha transcription factor network—VEGFA—melanoma	1.96e-05	0.00134	CbGpPWpGaD
Cilazapril—ACE—Metabolism of proteins—CXCL8—melanoma	1.9e-05	0.0013	CbGpPWpGaD
Cilazapril—ABCB1—Integrated Pancreatic Cancer Pathway—FGF1—melanoma	1.87e-05	0.00127	CbGpPWpGaD
Cilazapril—ABCB1—Integrated Pancreatic Cancer Pathway—E2F1—melanoma	1.83e-05	0.00125	CbGpPWpGaD
Cilazapril—ABCB1—Integrated Pancreatic Cancer Pathway—PDGFRA—melanoma	1.81e-05	0.00123	CbGpPWpGaD
Cilazapril—ABCB1—Integrated Pancreatic Cancer Pathway—PRKCA—melanoma	1.79e-05	0.00122	CbGpPWpGaD
Cilazapril—ABCB1—Integrated Pancreatic Cancer Pathway—FASLG—melanoma	1.75e-05	0.0012	CbGpPWpGaD
Cilazapril—ACE—Metabolism of proteins—CTNNB1—melanoma	1.75e-05	0.0012	CbGpPWpGaD
Cilazapril—ABCB1—Integrated Pancreatic Cancer Pathway—PCNA—melanoma	1.72e-05	0.00117	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—ACER3—melanoma	1.71e-05	0.00117	CbGpPWpGaD
Cilazapril—ABCB1—Allograft Rejection—VEGFA—melanoma	1.7e-05	0.00116	CbGpPWpGaD
Cilazapril—ABCB1—Integrated Pancreatic Cancer Pathway—FAS—melanoma	1.69e-05	0.00115	CbGpPWpGaD
Cilazapril—ABCB1—Integrated Pancreatic Cancer Pathway—RAC1—melanoma	1.66e-05	0.00113	CbGpPWpGaD
Cilazapril—ABCB1—Integrated Pancreatic Cancer Pathway—CDK2—melanoma	1.58e-05	0.00107	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—UGT2B10—melanoma	1.57e-05	0.00107	CbGpPWpGaD
Cilazapril—SLC15A2—Transmembrane transport of small molecules—ALB—melanoma	1.54e-05	0.00105	CbGpPWpGaD
Cilazapril—ABCB1—Integrated Pancreatic Cancer Pathway—ATM—melanoma	1.5e-05	0.00102	CbGpPWpGaD
Cilazapril—ABCB1—Integrated Pancreatic Cancer Pathway—CDK4—melanoma	1.49e-05	0.00102	CbGpPWpGaD
Cilazapril—ABCB1—Allograft Rejection—TNF—melanoma	1.46e-05	0.000993	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—HS3ST5—melanoma	1.46e-05	0.000993	CbGpPWpGaD
Cilazapril—SLC15A1—Transmembrane transport of small molecules—ALB—melanoma	1.43e-05	0.000974	CbGpPWpGaD
Cilazapril—ABCB1—Integrated Pancreatic Cancer Pathway—APC—melanoma	1.4e-05	0.000956	CbGpPWpGaD
Cilazapril—ABCB1—Integrated Pancreatic Cancer Pathway—EGF—melanoma	1.39e-05	0.000945	CbGpPWpGaD
Cilazapril—ABCB1—Integrated Pancreatic Cancer Pathway—CASP8—melanoma	1.31e-05	0.00089	CbGpPWpGaD
Cilazapril—ABCB1—Integrated Pancreatic Cancer Pathway—IGF1—melanoma	1.28e-05	0.000875	CbGpPWpGaD
Cilazapril—ABCB1—HIF-1-alpha transcription factor network—AKT1—melanoma	1.25e-05	0.000854	CbGpPWpGaD
Cilazapril—ABCB1—Integrated Pancreatic Cancer Pathway—MAP2K1—melanoma	1.24e-05	0.000846	CbGpPWpGaD
Cilazapril—ABCB1—Integrated Pancreatic Cancer Pathway—FGF2—melanoma	1.18e-05	0.000805	CbGpPWpGaD
Cilazapril—ABCB1—Integrated Pancreatic Cancer Pathway—BCL2—melanoma	1.12e-05	0.000764	CbGpPWpGaD
Cilazapril—ABCB1—Integrated Pancreatic Cancer Pathway—MDM2—melanoma	1.1e-05	0.000753	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—PLCB4—melanoma	1.1e-05	0.000752	CbGpPWpGaD
Cilazapril—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—melanoma	1.09e-05	0.000742	CbGpPWpGaD
Cilazapril—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—melanoma	1.06e-05	0.000726	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—PIP4K2A—melanoma	1.04e-05	0.000707	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—SLC6A11—melanoma	1.04e-05	0.000707	CbGpPWpGaD
Cilazapril—ABCB1—Transmembrane transport of small molecules—SLC5A5—melanoma	1.01e-05	0.000691	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—MTAP—melanoma	1.01e-05	0.000688	CbGpPWpGaD
Cilazapril—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1B—melanoma	1.01e-05	0.000687	CbGpPWpGaD
Cilazapril—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—melanoma	9.88e-06	0.000674	CbGpPWpGaD
Cilazapril—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—melanoma	9.62e-06	0.000656	CbGpPWpGaD
Cilazapril—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—melanoma	9.52e-06	0.000649	CbGpPWpGaD
Cilazapril—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1A—melanoma	9.3e-06	0.000634	CbGpPWpGaD
Cilazapril—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—melanoma	9.28e-06	0.000633	CbGpPWpGaD
Cilazapril—ABCB1—Integrated Pancreatic Cancer Pathway—NFKB1—melanoma	9.24e-06	0.00063	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—LUM—melanoma	8.99e-06	0.000613	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—PHGDH—melanoma	8.99e-06	0.000613	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—HPSE—melanoma	8.82e-06	0.000601	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—CUBN—melanoma	8.66e-06	0.00059	CbGpPWpGaD
Cilazapril—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—melanoma	8.38e-06	0.000572	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—BSG—melanoma	8.36e-06	0.00057	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—CSPG4—melanoma	8.36e-06	0.00057	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—SDHD—melanoma	8.36e-06	0.00057	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—GPAM—melanoma	8.1e-06	0.000552	CbGpPWpGaD
Cilazapril—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK3—melanoma	7.93e-06	0.000541	CbGpPWpGaD
Cilazapril—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—melanoma	7.71e-06	0.000526	CbGpPWpGaD
Cilazapril—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK1—melanoma	7.55e-06	0.000515	CbGpPWpGaD
Cilazapril—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—melanoma	7.54e-06	0.000515	CbGpPWpGaD
Cilazapril—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—melanoma	7.18e-06	0.00049	CbGpPWpGaD
Cilazapril—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—melanoma	7.13e-06	0.000486	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—PLA2G6—melanoma	6.88e-06	0.00047	CbGpPWpGaD
Cilazapril—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—melanoma	6.55e-06	0.000447	CbGpPWpGaD
Cilazapril—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—melanoma	6.33e-06	0.000432	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—VCAN—melanoma	6.18e-06	0.000422	CbGpPWpGaD
Cilazapril—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—melanoma	5.35e-06	0.000365	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—CYP17A1—melanoma	5.22e-06	0.000356	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—GNA11—melanoma	4.93e-06	0.000336	CbGpPWpGaD
Cilazapril—ABCB1—Transmembrane transport of small molecules—ALB—melanoma	4.83e-06	0.000329	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—FASN—melanoma	4.82e-06	0.000329	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—SLC5A5—melanoma	4.74e-06	0.000323	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—GNAQ—melanoma	4.58e-06	0.000312	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—CD44—melanoma	4.58e-06	0.000312	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—CYP1B1—melanoma	4.39e-06	0.0003	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—PRKCA—melanoma	3.33e-06	0.000227	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—ERCC2—melanoma	3.3e-06	0.000225	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—PIK3CG—melanoma	2.61e-06	0.000178	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—PPARG—melanoma	2.52e-06	0.000172	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—PIK3CD—melanoma	2.29e-06	0.000156	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—ALB—melanoma	2.26e-06	0.000154	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—PIK3CB—melanoma	2e-06	0.000136	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—PTGS2—melanoma	1.98e-06	0.000135	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—PTEN—melanoma	1.73e-06	0.000118	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—PIK3CA—melanoma	1.22e-06	8.3e-05	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—AKT1—melanoma	9.95e-07	6.78e-05	CbGpPWpGaD
